|
Jul 23
|
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
|
|
Jun 24
|
Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories
|
|
Jun 20
|
Roche launches B-cell lymphoma diagnostic assay in Europe
|
|
Jun 20
|
Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma
|
|
Jun 19
|
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
|
|
Jun 19
|
Ascidian and Roche to develop RNA therapies for neurological diseases
|
|
Jun 18
|
Roche gains 501(k) clearance for digital pathology solution for diagnostic use
|
|
Jun 18
|
Roche partners with RNA editing biotech Ascidian
|
|
Jun 18
|
Roche receives FDA clearance on its digital pathology solution for diagnostic use
|
|
Jun 17
|
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
|
|
Apr 12
|
Roche scores FDA breakthrough status for Alzheimer’s blood test
|
|
Apr 12
|
Roche, Adaptimmune part ways on cell therapy research
|
|
Apr 11
|
Why Roche Holdings Stock Popped Today
|
|
Apr 11
|
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
|
|
Apr 11
|
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
|
|
Apr 10
|
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
|
|
Apr 10
|
Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Feb 15
|
Cancer test firm Freenome raises $254 mln in fresh funding
|
|
Feb 13
|
Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics
|